Clinical trials
Enrolling by invitation trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 8 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 5 |
| QED Therapeutics, a BridgeBio company | 3 |
| Changi General Hospital | 2 |
| Tan Tock Seng Hospital | 2 |
| National Heart Centre Singapore | 1 |
| National University Health System, Singapore | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| SingHealth Polyclinics | 1 |
| Singapore Eye Research Institute | 1 |
| Singapore General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases | 3 |
| Breast Neoplasms | 3 |
| Genetic Diseases, Inborn | 3 |
| Mucopolysaccharidosis IV | 3 |
| Musculoskeletal Diseases | 3 |
| Osteochondrodysplasias | 3 |
| Dwarfism | 2 |
| Hypertension | 2 |
| Achondroplasia | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.